CLINICAL_TRIALS
trial_result
· 2022-12-07
Clinical Trial Update: Saccharomyces Cerevisiae for Irritable Bowel Syndrome [Phase 1, Phase 2]
Summary
A clinical trial update for Saccharomyces cerevisiae conducted in Irritable Bowel Syndrome across Phase 1 and Phase 2 has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ziauddin University | Conditions: Irritable Bowel Syndrome | Phase 1, Phase 2 | Status: COMPLETED